Register
Login:
Share:
Email Facebook Twitter




Add Gw Pharmaceuticals to quick picks

Gw Pharmaceuticals Share Price (GWP)



Share Price Information for Gw Pharmaceuticals (GWP)


Share Price: 438.00Bid: 435.75Ask: 438.00Change: 0.00 (0.00%)No Movement on Gw Pharm.
Spread: 2.25Spread as %: 0.52%Open: 448.00High: 448.25Low: 431.50Yesterday’s Close: 438.00
InfoGet Live Streaming Prices for GWP - Click here to start your 30 day FREE trial today.


Gw Pharmaceuticals Plc Ord 0.1P

Gw Pharmaceuticals is listed in the FTSE AIM 100, FTSE AIM UK 50, FTSE AIM All-Share
Gw Pharmaceuticals is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
438.00

Share Price SpacerBid
435.75

Share Price SpacerAsk
438.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
167,104

Share Price SpacerOpen
448.00

Share Price SpacerHigh
448.25

Share Price SpacerLow
431.50

Share Price SpacerClose
438.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 237.16m £1,038.74m 3,000

52 Week High 541.00 52 Week High Date 1-JUL-2014
52 Week Low 205.00 52 Week Low Date 16-APR-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
334 85,229 81,009 -62.571 -7.00 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

27-Feb-15
16:35:27
441.9793
10,879
Buy* 
435.75
438.00
48.08k
Trade Type:
Ordinary
Bargain conditions apply

27-Feb-15
17:02:02
442.44
2,800
Buy* 
435.75
438.00
12.39k
Trade Type:
Ordinary
Bargain conditions apply

27-Feb-15
16:46:50
437.9562
21,612
Buy* 
435.75
438.00
94.65k
Trade Type:
Ordinary
Bargain conditions apply


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Gw Pharmaceuticals trades >>

Directors Deals for Gw Pharmaceuticals (GWP)
Trade DateActionNotifierPriceCurrencyAmountHolding
09-Feb-15Sell
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
404.2GBX10,0002500
09-Feb-15Sell
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
404.2GBX10,0002500
17-Dec-14Notification of Holding
Trade Notifier Information for GW Pharmaceuticals
Justin Gover held the position of CEO at GW Pharmaceuticals at the time of this trade.
 Justin Gover
002143315
View more Gw Pharmaceuticals directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Sat 16:00
kingskin
RE: ''Skunk-like cannabis'
438.00
No Opinion

even the yanks agree the research is flawed :) https://www.youtube.com/watch?v=YgLefrt3KMw&feature=youtu.be
Thu 13:25
drshaggy
RE: Sativex, potential time bomb!!
444.75
No Opinion

PPS: note in the Sativex profile Flowerpowerbob that the THC/CBD quantities are variable (within ranges). I was trying to say a while ago that with cannabis as a medicine it wouldn't have to be so fixed as it would be if it was synthetic in origin. It varies because the plants cannabinoid profile can vary in nature, even under identical conditions, precisely because of the horticultural variables I mentioned above. That's why THC and CBD-rich oils produced in the medical marijuana states are of no lesser quality than GWP's: they don't need to be exact quantities to work effectively. That's why cannabis is such a unique medicine.
Thu 13:16
drshaggy
RE: Sativex, potential time bomb!!
443.25
No Opinion

PS: I meant illegal to use weed/pest killers in states where the market is regulated, not where it's still illegal of course.
Thu 13:13
drshaggy
RE: Sativex, potential time bomb!!
446.50
No Opinion

The effect of reducing flowering time is to increase profit and turnaround. That suits the gangs because they make more money. It's not for horticultural reasons, because there are none. The plant's full cannabinoid profile hasn't fully developed by that time, so people are often ingesting nutrient-rich and effectively immature plants. Fully matured plants have a more balanced cannabinoid profile and are safer to use because they've had the excess nutrients flushed out of them. I don't think that GWP will be cropping early to increase crop turnaround. They'll be looking for the full cannabinoid profile that only comes with full maturity. The overuse of nutrients in cannabis production is an area that mental health researchers should be looking into. Excess plant nutrients in the human body can cause all sorts of health issues, including damaging effects to the central nervous system (ie: the brain). But of course, they're not really interested in anything else that might impact on human health. All licensed legal production facilities in the United States are indoors by the way. This is for both security and horticultural reasons - outdoor weed can cross-pollinate, get decimated by by pests (the dreaded spidermite) get contaminated or polluted. It's illegal to use pest and weedkillers killers on marijuana in the US. In the American states where medical and/or recreational marijuana is legal, there are also quality testing systems in place to check for problems like excess nutrients, heavy metals, mold and so on. It's not just a free-for -all over there. It's a regulated system, and is safer for it. It just seems strange that all the issues about mental health and cannabis all seem to emanate from the same researchers, mainly based in the same hospitals in the UK, Sweden and New Zealand, primarily led by Sir Robin Murray. All cite and re-cite the same research about the Swedish Army study cohort, The Dunedin Study and others. None of the findings these studies show have been repeated elsewhere. For example the Dunedin claim about IQ loss and cannabis use (reported agressively in the Daily Mail/Telegraph). A more extensive study in Bristol, based on years of research with children and developing adults over a period of years, found that the Dundedin findings couldn't be replicated. In other words, all this stuff about developing brains, cannabis and IQ loss wasn't true after all. Murray and co conveniently ignore anything that doesn't chime with their own research bias. Murray and co find what they want to find. The unregulated system in the UK has no quality control of course. Illegality doesn't 'control' usage. It abrogates responsibility and leaves it for the gangs to be able to sell any old crap. Hence, the grit-weed, the nutrient-rich, the immature and unbalanced weed you get on the streets. A regulated system would impact on the gangland free-for all that happens over here.
Thu 11:32
FlowerPowerBob
RE: Sativex, potential time bomb!!
442.00
No Opinion

Thanks - very interesting. I thought the reason why indoor growers crop the cannabis shorter was because of reducing down crop times (i.e more crops per year) for commercial reasons and because of horticultural reasons i.e increasing air movement, not getting the crops too close to the supplementary lights? I'm sure prohibition has got something to do with it as well but do growers in the US now grow outside or in taller structures? Or are they still growing in sheds / enclosed buildings? I heard of a project in Canada growing cannabis in a large building / factory - indoors - with supplementary lighting. I could only think that was because of security rather than growing conditions. I would imagine a modern glasshouse with thermal screens etc will always be better and cheaper to run than enclosed structures with LEDs, etc.
Thu 09:23
drshaggy
RE: Sativex, potential time bomb!!
447.25
No Opinion

What Sativex contains: The active substances are cannabis extracts. Each millilitre (ml) contains 38-44 mg and 35-42 mg of two extracts (as soft extracts) from Cannabis sativa L., leaf and flower, corresponding to 27 mg/ml delta-9-tetrahydrocannabinol (THC) and 25 mg/ml cannabidiol (CBD). Each 100 microlitre spray contains 2.7 mg THC and 2.5 mg CBD. Sativex is a 1:1 ratio of THC/CBD Basically Sativex combines two full plant extracts. The THC content of the THC-rich plant was claimed to be 98% by Justin Glover during a presentation that can be viewed on the internet. I think his claim is misleading, because I think he's actually referring to the % of the extract itself, rather than the raw plant content. The second plant is a CBD rich cannabis strain (not hem itselfp, the CBD from hemp doesn't function in the same way as CBD with THC because of the entourage effect of THC/CBD, hence Charlotte's Web strain rather than just growing any old hemp). The CBD content in so-called skunk varieties varies according to strain and also is particularly dependent on the length of the flowering period a given strain is subjected to.. Chinese/Vietnamese gangs reduce the flowering period by cropping early to get the crop to market (a consequence of prohibition itself of course). These early cropped strains have lower amount of CBD because CBD appears later in the flowering process. The gangs crop early to obtain the highest strength, not the more balanced THC/CBD product that comers with waiting a couple of weeks longer. This is the difference between what's being sold legally in the US and that which is grown here illegally. Prohibition itself has created this problem.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Gw Pharmaceuticals (GWP) >>
Please Login or Register to post messages



Gw Pharmaceuticals Plc Ord 0.1P home pageWebsite: Gw Pharmaceuticals Plc Ord 0.1P
Website Description: GW Pharmaceutical



Sign up for Live Prices


CD02WL.001.081313


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.